You are now being logged in using your Facebook credentials
Voter Outreach

Voter Outreach

Concepts, strategies and objectives to move voters to action

Written by Peter Grear Educate, Organize and Mobilize: Each week over the past several months I’ve written about various aspects of voter suppression with the purpose of explaining its concepts,…

Read More...
Keatts A Keeper For New-Look Seahawks

Keatts A Keeper For New-Look Seahawks

New Head Men’s Basketball Coach was all smiles

New Head Men’s Basketball Coach was all smiles at Trask Coliseum. WILMINGTON, NC – Boldly proclaiming, “I’m a winner,” and promising “an exciting brand of basketball” newly-christened UNCW head men’s basketball coach Kevin Keatts said Tuesday that a new day in Seahawk basketball has arrived.

Read More...
Lied-to Children More Likely to Cheat and Lie

Lied-to Children More Likely to Cheat and Lie

The study tested 186 children ages 3 to 7

The study tested 186 children ages 3 to 7 in a temptation-resistance paradigm. Approximately half of the children were lied to by an experimenter, who said there was “a huge bowl of candy in the next room” but quickly confessed this was just a ruse to get the child to come play a game. 

Read More...
Unconscious Mind Can Detect a Liar When Conscious Mind Fails

Unconscious Mind Can Detect a Liar When Conscious Mind Fails

The unconscious mind could catch a liar

“We set out to test whether the unconscious mind could catch a liar – even when the conscious mind failed,” says ten Brinke. Along with Berkeley-Haas Assistant Professor Dana R. Carney, lead author ten Brinke and Dayna Stimson (BS 2013, Psychology), hypothesized that these seemingly paradoxical findings may be accounted for by unconscious mental processes.

Read More...
Alliance of North Carolina Black Elected Officials: Educate, Organize, and Mobilize

Alliance of North Carolina Black Elected Officials: Educate, Organize, and Mobilize

North Carolina Alliance of Black Elected Officials

Written by Peter Grear, Esq.  Since August 2013 I've continued to ask myself "what would an effective campaign to defeat voter suppression look like?” Well, on Friday, February 14, 2014, Valentine's Day, I got my answer from Richard Hooker, President of the…

Read More...
Download Greater Diversity News Digital PDF Edition for FREE

Download Greater Diversity News Digital PDF Edition for FREE

FREE Full PDF Edition includes stories not featured on the website

The FREE Full PDF Edition includes stories not featured on the website. No paper, no hasel, read on your laptop or mobile devices. 

Read More...
Frontpage Slideshow | Copyright © 2006-2011 JoomlaWorks Ltd.

Lilly and Wellpoint Top Execs to Participate in Conference on 'Personalized Medicine' on May 14

Written by Indiana University on 25 April 2010.

Lilly and Wellpoint Top Execs to Participate in Conference on 'Personalized Medicine' on May 14Anyone who has gone to a doctor is familiar with the process of providing a medical history. However, until recently it has been difficult for physicians to share with each other their personal observations and intuitions that allow others to provide the same individualized care.

With the advent of information technology, the term "personalized medicine" has taken on new dimensions. While it seems it's always been with us, the potential for a clearer pathway to more effective and efficient personalized or tailored medicine is now before us.

The final event in the 2009-10 Indiana Life Sciences Collaboration Conferences Series poses the question, "Personalized Medicine -- Are We There Yet?," as its theme. It will take place at Fairbanks Hall at the IU/Clarian Education and Resource Center, 340 W. 10th St., in Indianapolis, from 9 a.m. to 3:30 p.m., on Friday, May 14. Registration and networking begin at 8 a.m.

Speakers will include Dr. Samuel R. Nussbaum, chief medical officer of Wellpoint Inc.; John C. Lechleiter, chairman, president and chief executive officer of Eli Lilly & Co.; and Dr. Leroy Hood, president of the Institute for Systems Biology Networking.

"With the introduction of many technologies in recent years, health informatics and technology are paving the way to more effectively utilize diagnostic devices and biomarkers to better equip health care professionals to treat patients' individualized needs. The question now is, where do we go from here?," said George Telthorst, director of the Center for the Business of Life Sciences at Indiana University's Kelley School of Business.

"We are thrilled to have such a well-rounded group of experts representing the many components of the personalized medicine value chain giving their perspective on where we are headed and how patients, physicians, government, taxpayers and companies benefit," Telthorst added.

Following welcoming remarks from Daniel F. Evans, president and CEO of Clarian Health, Nussbaum will present "An Overview of Personalized Medicine." He will be followed by a "big picture" presentation from keynote speaker Lechleiter, who will be introduced by Harry L. Gonso, a partner in Ice Miller LLP, at 9:30 a.m.

At 10:45 a.m., a panel moderated by Dr. Jane Barlow, vice president of medical strategy and clinical quality for Personalized Medicine Solutions, Medco Inc., will discuss "The Science Behind the Business of Personalized Medicine." Panelists will include Dr. George W. Sledge Jr., the Ballve-Lantero professor in the IU School of Medicine and a team member at the IU Melvin and Bren Simon Cancer Center; Mark A. Suckow, director of the Freimann Life Science Center and a research associate professor in the Department of Biological Sciences at the University of Notre Dame; and Philip S. Low, the Ralph S. Corley Distinguished Professor of Biochemistry at Purdue University.

Hood will speak at lunch on the topic, "The Emergence of Personalized Medicine (P4) and How it Will Advance the Medicine of the Future."

At 1:30 p.m., a second panel will focus on "Personalized Medicine Business Start-ups: Lessons from the Field," moderated by R. Matthew Neff, president of Clarian Health Ventures. Panelists will be Tiffany Olson, vice president of diagnostics of Eli Lilly and Co.; P. Ron Ellis, president of Endocyte Inc.; Richard H. Selinfreund, president of Companion Diagnostics Inc.; and Linda H. Malkas, founder of CS-Keys Inc. and Syntherix Inc.

David L. Johnson, president and CEO of BioCrossroads, will provide closing comments.

Registration for the conference is available online at http://kelley.iu.edu/CBLS/conferences/registration/page16551.html or by contacting Roxie Glaze at the Kelley School at 812-855-9210 or rglaze@indiana.edu. The registration fee is $70. Indiana college students may qualify to attend at no charge (see registration site for details).

This conference is sponsored by Beckman Coulter, Clarian Health Ventures Inc., Ice Miller LLP, the IU School of Medicine, IU Clinical Translational Sciences Institute, the University of Notre Dame and Purdue University.